22-19880695-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006440.5(TXNRD2):​c.1109T>C​(p.Ile370Thr) variant causes a missense change. The variant allele was found at a frequency of 0.723 in 1,612,762 control chromosomes in the GnomAD database, including 426,057 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar.

Frequency

Genomes: 𝑓 0.77 ( 45518 hom., cov: 33)
Exomes 𝑓: 0.72 ( 380539 hom. )

Consequence

TXNRD2
NM_006440.5 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 5.83

Publications

62 publications found
Variant links:
Genes affected
TXNRD2 (HGNC:18155): (thioredoxin reductase 2) The protein encoded by this gene belongs to the pyridine nucleotide-disulfide oxidoreductase family, and is a member of the thioredoxin (Trx) system. Three thioredoxin reductase (TrxR) isozymes are found in mammals. TrxRs are selenocysteine-containing flavoenzymes, which reduce thioredoxins, as well as other substrates, and play a key role in redox homoeostasis. This gene encodes a mitochondrial form important for scavenging reactive oxygen species in mitochondria. It functions as a homodimer containing FAD, and selenocysteine (Sec) at the active site. Sec is encoded by UGA codon that normally signals translation termination. The 3' UTRs of selenoprotein mRNAs contain a conserved stem-loop structure, the Sec insertion sequence (SECIS) element, which is necessary for the recognition of UGA as a Sec codon rather than as a stop signal. Alternatively spliced transcript variants encoding different isoforms, including a few localized in the cytosol and some lacking the C-terminal Sec residue, have been found for this gene. [provided by RefSeq, Jun 2017]
TXNRD2 Gene-Disease associations (from GenCC):
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial glucocorticoid deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • dilated cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • glucocorticoid deficiency 5
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=2.917005E-6).
BP6
Variant 22-19880695-A-G is Benign according to our data. Variant chr22-19880695-A-G is described in ClinVar as Benign. ClinVar VariationId is 263369.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.909 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006440.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TXNRD2
NM_006440.5
MANE Select
c.1109T>Cp.Ile370Thr
missense
Exon 13 of 18NP_006431.2
TXNRD2
NM_001352300.2
c.1106T>Cp.Ile369Thr
missense
Exon 13 of 17NP_001339229.1
TXNRD2
NM_001352301.2
c.1019T>Cp.Ile340Thr
missense
Exon 13 of 18NP_001339230.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TXNRD2
ENST00000400521.7
TSL:1 MANE Select
c.1109T>Cp.Ile370Thr
missense
Exon 13 of 18ENSP00000383365.1
TXNRD2
ENST00000400519.6
TSL:1
c.1106T>Cp.Ile369Thr
missense
Exon 13 of 17ENSP00000383363.1
TXNRD2
ENST00000400518.5
TSL:1
c.1019T>Cp.Ile340Thr
missense
Exon 13 of 18ENSP00000383362.1

Frequencies

GnomAD3 genomes
AF:
0.766
AC:
116456
AN:
152004
Hom.:
45452
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.917
Gnomad AMI
AF:
0.892
Gnomad AMR
AF:
0.658
Gnomad ASJ
AF:
0.779
Gnomad EAS
AF:
0.603
Gnomad SAS
AF:
0.581
Gnomad FIN
AF:
0.685
Gnomad MID
AF:
0.797
Gnomad NFE
AF:
0.734
Gnomad OTH
AF:
0.777
GnomAD2 exomes
AF:
0.691
AC:
171567
AN:
248132
AF XY:
0.689
show subpopulations
Gnomad AFR exome
AF:
0.920
Gnomad AMR exome
AF:
0.563
Gnomad ASJ exome
AF:
0.767
Gnomad EAS exome
AF:
0.592
Gnomad FIN exome
AF:
0.685
Gnomad NFE exome
AF:
0.740
Gnomad OTH exome
AF:
0.706
GnomAD4 exome
AF:
0.719
AC:
1049835
AN:
1460640
Hom.:
380539
Cov.:
54
AF XY:
0.716
AC XY:
520024
AN XY:
726630
show subpopulations
African (AFR)
AF:
0.926
AC:
31012
AN:
33476
American (AMR)
AF:
0.578
AC:
25854
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.769
AC:
20107
AN:
26134
East Asian (EAS)
AF:
0.630
AC:
25023
AN:
39700
South Asian (SAS)
AF:
0.586
AC:
50558
AN:
86244
European-Finnish (FIN)
AF:
0.688
AC:
36087
AN:
52446
Middle Eastern (MID)
AF:
0.784
AC:
4519
AN:
5764
European-Non Finnish (NFE)
AF:
0.731
AC:
813035
AN:
1111798
Other (OTH)
AF:
0.723
AC:
43640
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
15515
31030
46545
62060
77575
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19970
39940
59910
79880
99850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.766
AC:
116583
AN:
152122
Hom.:
45518
Cov.:
33
AF XY:
0.758
AC XY:
56369
AN XY:
74358
show subpopulations
African (AFR)
AF:
0.917
AC:
38097
AN:
41556
American (AMR)
AF:
0.658
AC:
10057
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.779
AC:
2703
AN:
3470
East Asian (EAS)
AF:
0.602
AC:
3098
AN:
5142
South Asian (SAS)
AF:
0.582
AC:
2803
AN:
4820
European-Finnish (FIN)
AF:
0.685
AC:
7244
AN:
10582
Middle Eastern (MID)
AF:
0.799
AC:
235
AN:
294
European-Non Finnish (NFE)
AF:
0.734
AC:
49899
AN:
67966
Other (OTH)
AF:
0.777
AC:
1635
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1360
2721
4081
5442
6802
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
850
1700
2550
3400
4250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.746
Hom.:
132245
Bravo
AF:
0.773
TwinsUK
AF:
0.726
AC:
2691
ALSPAC
AF:
0.722
AC:
2781
ESP6500AA
AF:
0.916
AC:
3747
ESP6500EA
AF:
0.738
AC:
6182
ExAC
AF:
0.700
AC:
84557
Asia WGS
AF:
0.617
AC:
2148
AN:
3478
EpiCase
AF:
0.749
EpiControl
AF:
0.750

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Glucocorticoid deficiency 5 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
Sep 09, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Primary dilated cardiomyopathy Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Cardiovascular phenotype Benign:1
Mar 11, 2015
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.62
T
BayesDel_noAF
Benign
-0.52
CADD
Benign
17
DANN
Benign
0.78
DEOGEN2
Benign
0.12
T
Eigen
Benign
-0.65
Eigen_PC
Benign
-0.43
FATHMM_MKL
Benign
0.035
N
LIST_S2
Benign
0.58
T
MetaRNN
Benign
0.0000029
T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
-0.59
N
PhyloP100
5.8
PrimateAI
Benign
0.41
T
PROVEAN
Benign
-1.4
N
REVEL
Benign
0.14
Sift
Benign
0.22
T
Sift4G
Benign
0.18
T
Polyphen
0.0
B
Vest4
0.11
MPC
0.26
ClinPred
0.028
T
GERP RS
5.4
PromoterAI
0.020
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.13
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1139793; hg19: chr22-19868218; COSMIC: COSV68691528; API